Collegium Pharmaceutical, Inc. (COLL)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$32.74
-0.12%
Mkt Cap $1.02B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $206.36M | $205.45M | -0.44% | $2.14 | $2.04 | -4.67% | — | — |
| Q4 2025 Nov 6, 2025 | $206.16M | $209.36M | +1.55% | $1.86 | $2.25 | +20.97% | — | — |
| Q3 2025 Aug 7, 2025 | $191.31M | $188.00M | -1.73% | $1.62 | $1.68 | +3.70% | — | — |
| Q2 2025 May 8, 2025 | $173.08M | $177.76M | +2.70% | $1.43 | $1.49 | +4.20% | — | — |
| Q1 2025 Feb 27, 2025 | $179.68M | $181.95M | +1.26% | $1.54 | $1.77 | +14.94% | — | — |
| Q4 2024 Nov 7, 2024 | $179.48M | $159.30M | -11.25% | $1.59 | $1.61 | +1.26% | — | — |
| Q3 2024 Aug 8, 2024 | $143.94M | $145.28M | +0.93% | $1.49 | $1.62 | +8.72% | — | — |
| Q2 2024 May 9, 2024 | $146.94M | $144.92M | -1.37% | $1.47 | $1.45 | -1.36% | — | — |
| Q1 2024 Feb 22, 2024 | $147.98M | $149.75M | +1.19% | $1.38 | $1.58 | +14.49% | — | — |
| Q4 2023 Nov 7, 2023 | $138.53M | $136.71M | -1.31% | $1.22 | $1.34 | +9.84% | — | — |
| Q3 2023 Aug 3, 2023 | $138.40M | $135.55M | -2.06% | $1.22 | $1.26 | +3.28% | — | — |
| Q2 2023 May 4, 2023 | $138.47M | $144.77M | +4.55% | $1.33 | $1.32 | -0.75% | — | — |
| Q1 2023 Feb 23, 2023 | $125.22M | $129.62M | +3.52% | $1.09 | $1.09 | +0.00% | — | — |
| Q4 2022 Nov 3, 2022 | $124.38M | $127.01M | +2.12% | $1.38 | $1.10 | -20.29% | — | — |
| Q3 2022 Aug 4, 2022 | $121.13M | $123.55M | +1.99% | $1.44 | $0.13 | -90.97% | — | — |
| Q2 2022 May 10, 2022 | $78.67M | $83.75M | +6.46% | $0.90 | $0.60 | -32.96% | — | — |
| Q1 2022 Feb 24, 2022 | $81.53M | $27.36M | -66.44% | $1.04 | -$0.73 | -170.19% | — | — |
| Q4 2021 Nov 4, 2021 | $85.13M | $78.84M | -7.39% | $0.95 | $0.22 | -76.84% | — | — |
| Q3 2021 Aug 5, 2021 | $84.77M | $82.94M | -2.16% | $0.34 | $0.27 | -20.59% | — | — |
| Q2 2021 May 6, 2021 | $83.33M | $87.72M | +5.26% | $0.42 | $0.41 | -2.38% | — | — |